Neurotrophin-Trk receptor interactions in neoplasia: A possible role in interstitial and perineural invasion in ductal pancreatic cancer

Critical Reviews in Oncogenesis

Volumn 7, Issue 1-2, 1996, Pages 89-100

  Miknyoczki, Shiela J ^a   Klein Szanto, Andres J P ^a,b   Ruggeri, Bruce A ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

adeno carcinoma; invasion; nerve growth factor; nerves; neurotrophin receptors; neurotrophins; pancreas; tumor progression

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR;

CELL INVASION; HUMAN; PANCREAS CANCER; REVIEW; TUMOR GROWTH;

EID: 0030429531     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v7.i1-2.60     Document Type: Review

References (109)

1. Gotz, R., R. Koster, C. Winkler, F. Raulf, F. Lottspelch, M. Schartl, and H. Thoenen: Neurotrophin-6 is a new member of the nerve growth factor family. Nature, 372:266-269 (1994).
2. Ip, N. Y. and G. D. Yancopoulos: Neurotrophic factors and their receptors. Prog. Brain Res., 105:189-195 (1995).
3. Maness, L. M., A. J. Kastin, J. T. Weber, W. A. Banks, B. S. Beckman, and J. E. Zadina: The neurotrophins and their receptors: structure, function, and neuropathology. Neurose. Biobehav. Rev., 18:143-159 (1994).
4. McDonald, N. Q. and M. V. Chao: Structural determinants of neurotrophin action. J. Biolog. Chem., 270:19669-19672 (1995).
5. Ibanez, C. F.: Neurotrophic factors: From structure-function studies to designing effective therapeutics. Trends Biotech., 13:217-227 (1995).
6. Ip, N. and G. D. Yancopoulos: Neurotrophic factors and their receptors. Ann. Neurol., 35: S13-S16 (1994).
7. Ip, N.Y., C. F. Ibanez, S. H. Nye, J. McClain, P. F. Jones, D. R. Gies, L. Belluscio, M. M. LeBeau, R. Espinosa, III, S. P. Squinto, H. Persson, and G. Yancopoulos: Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc. Natl. Acad. Sci., U.S.A., 89:3060-3064 (1992).
8. Timmusk, T., N. Belluardo, M. Metsis, and H. Persson: Widespread and developmentally-regulated expression of neurotrophin-4 messenger RNA in rat brain and peripheral tissues. Eur. J. Neurosci., 5:605-613 (1993).
9. Shibayama, E. and H. Koiziumi: Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. Am. J. Pathol., 148:1807-1818 (1996).
10. Sternini, C., D. Su, J. Arakawa, R. DeGiorgio, and N. C. Brecha: Evidence for a role of neurotrophin-3 in the adult digestive system. Gastroenterology, 108:A1008 (1996).
11. Segal, R. A. and M. E. Greenberg: Intracellular signaling pathways activated by neurotrophic factors. Ann. Rev. Neurosci., 19:463-489 (1996).
12. Davies, A. M.: Paracrine and autocrine actions of neurotrophic factors. Neurochem. Res., 21:749-753 (1996).
13. Snider, W. D.: Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell, 77:627-638 (1994).
14. Farinas, I., K. R. Jones, C. Backus, X. Wang, and L. P. Reichardt: Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature, 369:658-661 (1994).
15. Liu, X., P. Ernfors, H. Wu, and R. Jaenisch: Sensory but not motor neuron deficits in mice lacking NT-4 and BDNF. Nature, 375:238-241 (1995).
16. Ibanez, C. F.: Neurotrophin 4: the odd one out in the neurotrophin family. Neurochem. Res., 21:787-793 (1996).
17. Barde, Y. A.: Trophic factors and neuronal survival. Neuron, 2:1525-1534 (1989).
18. Greene, L. A. and D. R. Kaplan: Early events in neurotrophin signalling via Trk and p75 receptors. Curr. Opin. Neurobiol., 5:579-587 (1995).
19. Carter, B. D., C. Kaltschmidt, B. Kaltschmidt, N. Offenhauser, R. Bohm-Matthaei, P. A. Baeuerleand Y. A. Barde: Selective activation of NF-kB by nerve growth factor through the neurotrophin receptor p75. Science, 272:542-545 (1996).
20. NTR: a receptor after all. Science, 272:506-507 (1996).
21. Curtis, R., K. M. Adryan, J. L. Stark, J. S. Park, D. L. Compton, G. Weskamp, L. J. Huber, M. V. Chao, R. Jaenisch, K. F. Lee, R. M. Lindsay, and P. S. Distefano: Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins. Neuron, 14:1201-1211 (1995).
22. Rabizadeh, S., J. Oh, L.-T. Zhong, J. Yang, C. M. Bitler, L. L. Butcher, and D. E. Bredesen: Induction of apoptosis by the low-affinity NGF receptor. Science, 261:345-348 (1993).
23. Chapman, B.: A region of the 75-kDa neurotrophin receptor homologous to the death domains of TNFR-1 and Fas. FEBS Lett., 374:216-220 (1995).
24. Lamballe, F., R. Klein, and M. Barbacid: The Trk family of oncogenes and neurotrophin receptors. In: Multistage Carcinogenesis, C. C. H. et al., Ed., CRC Press, Boca Raton, 153-170 (1992).
25. Barbacid, M.: Structural and functional properties of the Trk family of neurotrophin receptors. Ann. NY Acad. Sci., 766:442-458 (1995).
26. Berkemeir, L. R., J. W. Winslow, D. R. Kaplan, K. Nikolics, D. V. Goeddel, and A. Rosenthal: Neurotrophin 5: a novel neurotrophic factor that activates TrkA and TrkB. Neuron, 7:857-866 (1991).
27. Chao, M. V.: Neurotrophin receptors: a window into neuronal differentiation. Neuron, 9:583-593 (1992).
28. Klein, R., D. Conway, L. F. Parada, and M. Barbacid: The TrkB tyrosine protein kinase gene encodes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell, 61:647-656 (1990).
29. Valenzuela, D. M., P. C. Maisonpierre, D. J. Glass, E. Rojas, L. Nunez, Y. Kong, D. R. Gries, T. N. Stitt, N. Y. Ip, and G. D. Yancopoulous: Alternative forms of rat TrkC with different functional capabilities. Neuron, 10:963-974 (1993).
30. Eide, F. F., E. R. Vining, B. L. Eide, K. Zang, X.-Y. Wang, and L. F. Reichardt: Naturally-occurring truncated TrkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J. Neurosci., 16:3123-3129 (1996).
31. Nakamura, T., R. Sanokawa, Y. Sasaki, D. Ayusawa, M. Oishi, and N. Mori: N-sch: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway. Oncogene, 13:1111-1121 (1996).
32. Obermeier, A., H. Halfter, K. H. Wiesmuller, G. Jung, J. Schlessinger, and A. Ullrich: Tyrosine 785 is a major determinant of Trk-substrate interaction. EMBO J., 12:933-941 (1993).
33. Stephens, R. D., D. Loeb, T. Copelan, T. Pawson, L. Greene and D. Kaplan: Trk receptors use redundant signal transduction pathways involving SHC and PLC gama 1 to mediate NGF responses. Neuron, 12:691-705 (1994).
34. Ohmichi, M., S. Decker, and A. Saltiel: Activation of phosphatidyl inositol 3-kinase by nerve growth factor involves indirect coupling of the Trk protooncogene with src homology 2 domains. Neuron, 9:769-777 (1992).
35. Perg, X., L. Greene, U. Kaplan, and R. Stephens: Deletion of a conserved juxtamembrane sequence in Trk abolishes NGF-promoted neuritogenesis. Neuron, 15:395-406 (1995).
36. Yao, R. and G. Cooper: Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science, 267:2003-2006 (1995).
37. Laurenzi, M. A., G. Barbany, T. Timmusk, J. A. Lindgren, and H. Persson: Expression of mRNA encoding neurotrophins and neurotrophin receptors in rat thymus, spleen tissue, and immunocompetent cells: regulation of neurotrophin-4 mRNA expression by mitogens and leukotriene B4. Eur. J. Biochem., 223:733-741 (1994).
38. Pflug, B. R., C. Dionne, D. R. Kaplan, J. Lynch, and D. Djakiew: Expression of a Trk high affinity nerve growth factor receptor in the human prostate. Endocrinology, 136:262-268 (1995).
39. Parvinen, M., M. Pelto-Huikko, O. Soder, R. Schultz, A. Kaipia, P. Mali, J. Toppari, H. Hakovirta, P. Lonnerberg, E. M. Ritzen, T. Ebendal, L. Olson, T. Hokfelt, and H. Persson: Expression of b-nerve growth factor and its receptor in rat seminiferous epithelium: specific function at the onset of meiosis. J. Cell Biol., 117:629-641 (1992).
40. Belkind-Gerson, J., S. Park, J. D. Lewis, and L. M. Kaplan: Several neurotrophins and ciliary neurotrophic factor are specifically expressed by rat and human intestinal epithelial cells. Gastroenterology, 110:A791 (1996).
41. Donovan, M. J., R. C. Miranda, R. Kraemer, T. A. McCaffrey, L. Tessarollo, D. Mahadeo, S. Sharif, D. R. Kaplan, P. Tsoulfas, L. Parada, C. D. Toran-Allerand, D. P. Hajjar and B. L. Hempstead: Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Am. J. Pathol., 147:309-324 (1995).
42. Hamestad, J., M. B. Levanti, and J. A. Vega: Distribution of neurotrophin receptors in human palatine tonsils: an immunohistochemical study. J. Neuroimmunol., 58:131-137 (1995).
43. Lomen, H. C., and E. M. Shooter: Widespread neurotrophin receptor expression in the immune system and other non-neuronal rat tissues. J. Neurochem., 64:1780-1789 (1995).
44. NGFR, TrkA, TrkB, and TrkC) in the adult human peripheral nervous system and nonneural tissues. Neurochem. Res., 21:929-938 (1996).
45. Klein, R., F. Lamballe, S. Bryant, and M. Barbacid: The TrkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron, 8:947-956 (1992).
46. Gordon-Cardo, C., P. Tapley, S. Jing, V. Nanduri, E. O'Rourke, F. Lamballe, K. Kovary, K. Klein, K. R. Jones, L. F. Reichardt, and M. Barbacid: The Trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell, 66:173-183 (1991).
47. Oelmann, E., L. Sreter, I. Schuller, H. Serve, M. Koenigsmann, B. Wiedenmann, D. Oberberg, B. Reufi, E. Thiel, and W. E. Berdel: Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling. Cancer Res., 55:2212-2219 (1995).
48. Mitsiadis, T. A., J. Wroblewski, J.-L. Urdiales, E. Becker, D. Martin-Zanca, B. B. Rudkin, and U. Lendahl: Expression of Trk receptors during cartilage differentiation. Ann. N.Y. Acad. Sci., 785:298-300 (1996).
49. Djakiew, D., R. Delsite, B. Pflug, J. Wrathall, J. H. Lynch, and M. Onoda: Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate. Cancer Res., 51:3304-3310 (1991).
50. Ojeda, S. R., G. A. Dissen, and M. P. Junier: Neurotrophic factors and female sexual development. Frontiers Neuroendocrinol., 13:120-162 (1992).
51. Donovan, M., R. Hahn, L. Tessarollo, and B. L. Hempstead: Neurotrophin-3 is required for mamalian cardiac development: identification of an esential nonneuronal neurotrophin function. Nature Genet., 14:210-213 (1996).
52. Srivastava, D. and E. N. Olson: Neurotrophin-3 knocks heart off Trk. Nature Med., 2:1069-1071 (1996).
53. Baker, D. L., W. M. Molenaar, J. Q. Trojanowski, A. E. Evans, A. H. Ross, L. B. Rorke, R. J. Packer, V. M. Lee, and D. Pleasure: Nerve growth factor receptor expression in peripheral and central neuro-ectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland. Am. J. Pathol., 139:115-122 (1991).
54. Sariola, H., M. Saarma, K. Sainio, U. Arumae, J. Palgi, A. Vaahtokari, K. Thesleff, and A. Karavanov: Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science, 254:571-573 (1991).
55. Wheeler, E. F. and M. Bothwell: Spatiotemporal patterns of expression of NGF and the low-affinity NGF receptor in rat embryos suggest functional roles in tissue morphogenesis and myogenesis. J. Neurosci., 12:930-945 (1992).
56. Baron, P., E. Scarpini, G. Meola, I. Santilli, G. Conti, D. Pleasure, and G. Scarlato: Expression of the low-affinity NGF receptor during human muscle development, regeneration, and in tissue culture. Muscle Nerve, 17:276-284 (1994).
57. Seidl, K., A. Buchberger, and C. Erck: Expression of nerve growth factor and neurotrophin receptors in testicular cells suggest novel roles for neurotrophins outside the nervous system. Reprod. Fertil. Develop., 8:1075-1087 (1996).
58. Kubo, T., T. Nonomura, Y. Enokido, and H. Hatanaka: Brain derived neurotrophic factor can prevent apoptosis of rat cerebellar granule neurons in culture. Develop. Brain Res., 85:249-258 (1995).
59. Bresdesen, D. E.: Neural apoptosis. Ann. Neurol., 38:839-851 (1995).
60. Kawamoto, K., T. Okada, Y. Kannan, H. Ushio, M. Matsumoto, and H. Matsuda: Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the Trk protooncogene receptor. Blood, 86:4638-4644 (1995).
61. Pincelli, C., C. Magnoni, E. Grassilli, L. Benassi, D. Ottani, C. Franceschi, and A. Giannetti: Autocrine nerve growth factor protects keratinocytes from apoptosis through its high affinity receptor. J. Invest. Dermatol., 106:829 (1996).
62. Alhalabi, M. and A. S: The neurotrophins brain-derived neurotophic factor, NT-4/5, and NT-3 protect injured skeletal muscle from cell death. Ann. Neurol., 38:332-333 (1995).
63. Pincelli, C., C. Magnoni, E. Grassilli, L. Benassi, D. Ottani, C. Franceschi, and A. Gianetti: K252a, a high affinity NGF-Receptor (TRK), induces apoptosis in human keratinocytes. J. Invest. Dermatol., 105:471 (1995).
64. Marchetti, D., D. Menter, L. Jin, M. Nakajima, and G. L. Nicolson: Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. M. J. Cancer Res., 55:692-699 (1993).
65. Marchetti, D., D. J. McQuillan, W. C. Spohn, D. D. Carson, and G. Nicolson: Neurtrophin stimulation of human melanoma cell invasion: Selected enhancement of heparanarse activity and haparanase degradation of specific heparan sulfate subpopulations. Cancer Res., 56:2856-2863 (1996).
66. Marchetti, D., I. E. McCutcheon, M. J. Ross, and G. L. Nicolson: Inverse expression of neurotrophins and neurotrophin receptors at the invasion front of human melanoma brain metastases Int. J. Oncol., 7:87-94 (1995).
67. Matsumoto, K., R. K. Wada, J. M. Yamashiro, D. R. Kaplan, and C. J. Thiele: Expression of brain-derived neurotrophic factor and p145 TrkB affects survival differentiation, and invasiveness of human neuroblastoma cells. Cancer Res., 55:1798-1806 (1995).
68. Machida, C. M., J. D. Scott, and G. Ciment: NGF-induction of the metalloproteiinase transin/stromelysin in PC12 cells: involvment of multiple protein kinases. J. Cell Biol., 114:1037-1048 (1991).
69. Djakiew, D., B. R. Pflug, R. Delsite, M. Onoda, J. H. Lynch, G. Arand, and E. W. Thompson: Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res., 53:1416-1420 (1993).
70. Bold, R. J., J. Ishizuka, S. Rajaraman, J. R. Perez-Polo, C. M. Townsend, and J. C. Thompson: Nerve growth factor is a mitogen for a pancreatic carcinoid cell line. J. Neurochem., 64:2622-2628 (1995).
71. Donovan, M. J., B. Hempstead, L. J. Huber, D. Kaplan, P. Tsoulfas, M. Chao, L. Parada, and D. Schofield: Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors. Am. J. Pathol., 145:792-801 (1994).
72. Hoehner, J. C., L. Olsen, B. Sandstedt, D. R. Kaplan, and S. Pahhnan, S. Association of neurotrophin receptor expression and differentiation in human neuroblastoma. Am. J. Pathol., 147:102-113 (1995).
73. Washiyama, K., Y. Muragaki, L. B. Rorke, V. M.-Y. Lee, S. C. Feinstein, M. J. Radeke, D. Blumberg, D. R. Kaplan, and J. Q. Trojanowski: Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system. Am. J. Pathol., 148:929-940 (1996).
74. Ryden, M., R. Sehgal, C. Dominici, F. H. Schilling, C. F. Ibanez, and P. Kogner: Expression of mRNA for the neurotrophin receptor TrkC in neuroblastomas with favorable tumor stage and good prognosis. Br. J. Cancer, 74:773-779 (1996).
75. Nakagawara, A., C. Azar, N. Scavarda, and G. Brodeur: Expression and function of TrkB and BDNF in human neuroblastoma. Mol. Cell Biol., 14:759-764 (1994).
76. Scala, S., K. Wosikowski, P. Giannakokoo, P. Valle, J. L. Biedler, B. A. Spengler, B.A. Lucarelli, S. E. Bates, and C. J. Thiele: Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. Cancer Res., 56:3737-3742 (1996).
77. Murr, M. M., M. G. Sarr, A. J. Oishi, and J. A. van Heerden: Pancreatic Cancer. CA: A Cancer J. Clini., 44:304-318 (1994).
78. Steele, G. D., Jr, R. T. Osteen, D. P. Winchester, G. P. Murphy, and H. R. Menck: Clinical highlights from the national cancer data base: 1994. CA: A Cancer J. Clin., 44:71-80 (1994).
79. Pour, P. M., H. Egami, and Y. Takiyama: Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications. Gastroenterology, 100:529-536 (1991).
80. Nagakawa, T., M. Kayahara, K. Ueno, T. Ohta, I. Konishi, N. Ueda, and I. Miyazaki: A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer, 69:930-935 (1992).
81. Bockman, D. E., M. Buchler, and H. G. Beger: Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology, 107:219-230 (1994).
82. Tsang, W. and J. K. C. Chan: Neural invasion in intraductal carcinoma of the breast. Hum. Pathol., 23:202-204 (1992).
83. Tanaka, A., T. Watanabe, K. Okuno, and M. Yasutomi: Perineural invasion as a predictor of recurrence of gastric cancer. Cancer, 73:550-555 (1994).
84. Nagakawa, T., K. Mori, T. Nakano, M. Kadoya, H. Kobayashi, T. Akiyama, M. Kayahara, T. Ohta, K. Ueno, Y. Higashino, I. Konishi, and I. Miyazaki: Perineural invasion of carcinoma of the pancreas and biliary tract. Br. J. Surg., 80:610-621 (1993).
85. Yang, G. Y., T. M. Wheeler, M. W. Kattan, P. T. Scardino, and T. C. Thompson: Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index. Cancer, 78:1267-1271 (1996).
86. DiRenzo, M. F., R. Poulsom, M. Olivero, P. M. Comoglio, and N. R. Lemoine: Expression of the met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res., 55:1129-1138 (1995).
87. Leung, H. Y., W. J. Gullick, and N. R. Lemoine: Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int. J. Cancer, 59:667-675 (1994).
88. Leung, H. Y., C. M. Hughes, G. Kloppel, R. C. N. Williamson, and N. R. Lemoine: Localization of expression of fibroblast growth factors and their receptors in pancreatic adenocarcinoma by in situ hybridization. Int. J. Oncol., 4:1219-1223 (1994).
89. Yamanaka, Y., H. Friess, M. Buchler, H. G. Beger, E. Uchida, M. Onda, M. S. Kobrin, and M. Korc: Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res., 53:5289-5296 (1993).
90. Kobrin, M. S., Y. Yamanaka, H. Friess, M. E. Lopez, and M. Korc: Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res., 53:4741-4744 (1993).
91. Smith, J. J., R. Derynck, and M. Korc: Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for superagonist autocrine cycle. Proc. Nat. Acad. Sci., U.S.A., 84:7567-7570 (1987).
92. Lemoine, N. R., C. M. Hughes, C. M. Barton, R. Paulsom, R. E. Jeffrey, G. Kloppel, P. A. Hall, and W. J. Gullick: The epidermal growth factor receptor in human pancreatic cancer. J. Pathol., 166:7-12 (1992).
93. Friess, H., Y. Yamanaka, M. Buchler, M. S. Kobrin, E. Tahara, and M. Korc: Cripto, A. Member of the epidermal growth factor family is over-expressed in human pancreatic cancer and chronic pancreatitis. Int. J. Cancer, 56:668-674 (1994).
94. Ebert, M., M. Yokoyama, M. S. Kobrin, H. Friess, M. E. Lopez, M. W. Buchler, G. R. Johnson, and M. Korc: Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res., 54:3959-3962 (1994).
95. Davies, N., P. Kapur, J. Gillespie, P. J. Guillou, and G. J. Poston: Transforming growth factor a is trophic to pancreatic cancer in vivo. Gut. 34:1097-1098 (1993).
96. Friess, H., P. Berberat, M. Schilling, J. Kunz, M. Korc, and M. W. Buchler: Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. J. Molec. Med., 74:35-42 (1996).
97. Scharfmann, R., A. Tazi, M. Polak, C. Kanka, and P. Czernichow: Expression of functional nerve growth fac- tor receptors in pancreatic b-cell lines and fetal rat islets in primary culture. Diabetes, 42:1829-1836 (1993).
98. Kanaka-Gantenbein, C., A. Tazi, P. Czernichow, and R. Scharfmann: In Vivo presence of the high affinity nerve growth factor Trk-A in the rat pancreas: differential localization during pancreatic development. Endocrinology, 136:761-769 (1995).
99. Chesa, P. G., W. J. Rettig, T. M. Thomson, L. J. Old, and M. R. Melamed: Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues. J. Histochem. Cytochem., 36:383-389 (1988).
100. Oikawa, T., J. Hitomi, A. Kono, E. Kaneko, and K. Yamaguchi: Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells. Int. J. Pancreatol., 18:15-23 (1995).
101. Tapley, P., F. Lamballe, and M. Barbacid: K252a is a selective inhibitor of the tyrosine protein kinase activity of the Trk family of oncogenes and neurotrophin receptors. Oncogene, 7:371-381 (1992).
102. Knusel, B. and F. Hefti: K-252 compunds: modulators of neurotrophin signal transduction. J. Neurochem., 59:1987-1996 (1992).
103. Kase, H., K. Iwahishi, and Y. Matsuda: K-252a, a potent inhibitor of protein inhibitor of protein kinase C from microbial origin. J. Antibiot., 39:1059-1065 (1986).
104. Kuo, J. F., M. Shoji, Z. Kiss, P. R. Girard, E. Deli, K. Oishi, and W. R. Vogler: Protein kinase C in cell growth and differentiation. Adv. Exp. Mod. Biol., 255:8-20 (1989).
105. Kase, H., K. Iwahashi, S. Nakanishi, Y. Matsuda, K. Yamada, M. Takahashi, C. Murakata, A. Sato, and M. Kaneko: K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun., 142:436-440 (1987).
106. Nakanishi, S., K. Yamada, H. Kase, S. Nakamura, and Y. Nonomura: K-252a, a novel microbial product, inhibits smooth muscle myosin light chain kinase. J. Biol. Chem., 263:6215-6219 (1988).
107. Koizumi, S., M. L. Contreras, Y. Matsuda, T. Hama, P. Lazarovici, and G. Guroff: K-252a: a specific inhibitor of the action of nerve growth factor on PC-12 cells. J. Neurosci., 8:715-721 (1988).
108. Hashimoto, S.: K-252a, a potent protein kinase inhibitor blocks nerve growth factor-induced neurite out-growth and changes in the phosphorylation of proteins in PC12h cells. J. Cell Biol., 107:1531-1539 (1988).
109. Shelton, D.L., J. Sutherland, J. Gripp, T. Camerato, M. P. Armanini, H. S. Phillips, K. Caroll, S. D. Spender, and A. D. Levinson: Human Trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J. Neurosci., 15:477-491 (1995).